ES549438A0 - PROCEDURE FOR THE ISOLATION OF A MAMMALIAN GENE, SEPARATE TRANSMISSIBLE, ASSOCIATED WITH TUMOR METASTASIS - Google Patents

PROCEDURE FOR THE ISOLATION OF A MAMMALIAN GENE, SEPARATE TRANSMISSIBLE, ASSOCIATED WITH TUMOR METASTASIS

Info

Publication number
ES549438A0
ES549438A0 ES549438A ES549438A ES549438A0 ES 549438 A0 ES549438 A0 ES 549438A0 ES 549438 A ES549438 A ES 549438A ES 549438 A ES549438 A ES 549438A ES 549438 A0 ES549438 A0 ES 549438A0
Authority
ES
Spain
Prior art keywords
transmissible
isolation
procedure
separate
tumor metastasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549438A
Other languages
Spanish (es)
Other versions
ES8705043A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Original Assignee
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Institute for Biomedical Research filed Critical Whitehead Institute for Biomedical Research
Publication of ES549438A0 publication Critical patent/ES549438A0/en
Publication of ES8705043A1 publication Critical patent/ES8705043A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES549438A 1984-11-30 1985-11-29 Transmissible, mammalian genes associated with tumor metastasis. Expired ES8705043A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30

Publications (2)

Publication Number Publication Date
ES549438A0 true ES549438A0 (en) 1987-04-16
ES8705043A1 ES8705043A1 (en) 1987-04-16

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549438A Expired ES8705043A1 (en) 1984-11-30 1985-11-29 Transmissible, mammalian genes associated with tumor metastasis.

Country Status (13)

Country Link
EP (1) EP0203970A1 (en)
JP (1) JPS62501399A (en)
AU (1) AU5197986A (en)
DK (1) DK359486A (en)
ES (1) ES8705043A1 (en)
FI (1) FI863095A0 (en)
GR (1) GR852864B (en)
HU (1) HUT41837A (en)
IL (1) IL77157A0 (en)
NO (1) NO863066L (en)
PT (1) PT81584B (en)
WO (1) WO1986003226A1 (en)
ZA (1) ZA859070B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
DK0495910T3 (en) 1989-10-18 2002-01-14 Us Health Preparation and use of human nm23 H2 protein and directed antibodies
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
AU725186B2 (en) * 1995-11-16 2000-10-05 Baylor College Of Medicine Method for identifying metastatic sequences
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997025443A1 (en) * 1996-01-10 1997-07-17 The University Of Liverpool Metastasis inducing dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
CA2308565A1 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
WO1999046385A2 (en) 1998-03-13 1999-09-16 Baylor College Of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
AU5197986A (en) 1986-06-18
JPS62501399A (en) 1987-06-11
DK359486D0 (en) 1986-07-29
FI863095A (en) 1986-07-29
NO863066L (en) 1986-09-29
WO1986003226A1 (en) 1986-06-05
DK359486A (en) 1986-07-29
PT81584B (en) 1987-04-07
ZA859070B (en) 1986-07-30
NO863066D0 (en) 1986-07-29
GR852864B (en) 1986-03-28
EP0203970A1 (en) 1986-12-10
FI863095A0 (en) 1986-07-29
PT81584A (en) 1985-12-01
IL77157A0 (en) 1986-04-29
ES8705043A1 (en) 1987-04-16
HUT41837A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
ES549438A0 (en) PROCEDURE FOR THE ISOLATION OF A MAMMALIAN GENE, SEPARATE TRANSMISSIBLE, ASSOCIATED WITH TUMOR METASTASIS
ES507595A0 (en) A PROCEDURE FOR THE PRODUCTION OF A RECOMBINANT PLASMID.
IT8026172A0 (en) PROCEDURE FOR THE PRODUCTION OF INTERFERON.
ES492053A0 (en) A PROCEDURE FOR THE PRODUCTION OF A PLASMID.
ES540705A0 (en) A PROCEDURE FOR THE PREPARATION OF 17B-CARBAMOIL-N-MONOSUSTITUTED -O 17B-ACIL-4-AZA-5-ALFA-ANDROSTIEN-3-ONAS.
ES548568A0 (en) PROCEDURE FOR THE PRODUCTION OF PIGMENTARY MATERIAL.
ES492213A0 (en) A PROCEDURE FOR THE MANUFACTURE OF RECEPTION CLOSURES PROVIDED WITH LINING.
ES540609A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLO PIRIDINAS.
ES546872A0 (en) A PROCEDURE FOR THE PREPARATION OF AMINOALCOXIBENZOPIRANONES.
ES505581A0 (en) PROCEDURE FOR THE MANUFACTURE OF CATHODICALLY DEPOSITABLE ENAMELS.
ES539387A0 (en) PROCEDURE FOR THE REPASIVATION OF PHOSPHATE METALLIC SURFACES
ES541781A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOTIOPENES.
IT8020048A0 (en) PROCEDURE FOR THE MANUFACTURE OF PRODUCTS COATED WITH POLYURETHANES.
ES545299A0 (en) A METHOD FOR THE CONSTRUCTION OF A SYNTHETIC GENE FOR PRO-THEINE VIRAL TARGET
NO852045L (en) PROCEDURE FOR THE PREPARATION OF PHENOL foam.
IT8521675A0 (en) PROCEDURE FOR THE PREPARATION OF AN ELIXIR.
ES542882A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW SULFONILUREAS.
ES545439A0 (en) A PROCEDURE FOR THE PREPARATION OF 2-BENCIL-4- (4-PIRIDIL) -TIAZOLES.
ES550351A0 (en) PROCEDURE FOR THE PRODUCTION OF 8-ALPHA-ACILAMINO-ERGOLINS.
ES549265A0 (en) A PROCEDURE FOR THE PREPARATION OF A PROTEIN HYDROLYSIS.
ES541450A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW SPIRE-3-HETEROAZOLIDINDIONAS.
IT7928220A0 (en) PROCEDURE FOR THE PRODUCTION OF CUMENE.
ES519618A0 (en) PROCEDURE FOR THE PRODUCTION OF AN INSULATING MATERIAL.
ES555370A0 (en) A PROCEDURE FOR THE PREPARATION OF SUBSTRATES DERIVED FROM XANTHILIO.
ES506247A0 (en) A PROCEDURE FOR THE PRODUCTION OF A LINING FOR METALLURGICAL OVENS.